Alume Biosciences progressing with fluorescence study in patients undergoing head and neck surgery - Labiotech.eu

Alume Biosciences announces first patient dosed in a trial of a peptide-dye conjugate that highlight nerves with fluorescence during surgery.

Alume Biosciences, Inc. says the first patient has been dosed in a phase 3 pivotal study of ALM-488, a peptide-dye conjugate designed to highlight nerves with fluorescence in real time during surgery… [+2306 chars]

full article...